LINK: https://teams.microsoft.com/meet/276416077554087?p=aJx2WwoCX9fP6cwHbf

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Describe the pathophysiology and clinical manifestations of Alpha-1 Antitrypsin Deficiency.  (2) Apply current screening recommendations to identify patients at risk for Alpha-1 Antitrypsin Deficiency.  (3) Evaluate current and emerging treatment options for patients with Alpha-1 Antitrypsin Deficiency.

FACULTY DISCLOSURE:  Thomas Ardiles, MD, disclosed a former employment relationship with Grifols Shared Services North America. The relationship ended on April 17, 2026.

All relevant financial relationships have been identified and mitigated.

PLANNER DISCLOSURE: Jay Herd, MD, and Dipesh Bista, MD, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Mary Biggers at [email protected]